世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lung Pulmonary Airway Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4446
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、肺・気道疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、細胞毒性薬、抗生物質、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・肺・気道疾患治療の市場動向
・企業の競争状況、市場シェア
・肺・気道疾患治療の種類別市場規模と予測2016-2027（気管支拡張薬、細胞毒性薬、抗生物質、その他）
・肺・気道疾患治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・肺・気道疾患治療の北米市場規模2016-2027（アメリカ、カナダ）
・肺・気道疾患治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・肺・気道疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・肺・気道疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・肺・気道疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Boehringer Ingelheim International、AstraZeneca、Teva Pharmaceuticals、GSK、Novartis、Merck、Roche、Sanofi）
・結論

Lung (Pulmonary) Airway Disease include bronchiectasis, asthma and COPD.Disease narrow down or block the airways. Such breathing problems caused due to Lung (Pulmonary) Airway Disease may inhibit the body receiving sufficient oxygen.

Market Analysis and Insights: Global Lung Pulmonary Airway Disease Treatment Market
The global Lung Pulmonary Airway Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Pulmonary Airway Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Pulmonary Airway Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Pulmonary Airway Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Pulmonary Airway Disease Treatment market.

Global Lung Pulmonary Airway Disease Treatment Scope and Market Size
Lung Pulmonary Airway Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Pulmonary Airway Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bronchodilators
Cytotoxic Drugs
Antibiotics
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boehringer Ingelheim International
AstraZeneca
Teva Pharmaceuticals
GSK
Novartis
Merck
Roche
Sanofi

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Pulmonary Airway Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bronchodilators
1.2.3 Cytotoxic Drugs
1.2.4 Antibiotics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lung Pulmonary Airway Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lung Pulmonary Airway Disease Treatment Market Perspective (2016-2027)
2.2 Lung Pulmonary Airway Disease Treatment Growth Trends by Regions
2.2.1 Lung Pulmonary Airway Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Pulmonary Airway Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Lung Pulmonary Airway Disease Treatment Industry Dynamic
2.3.1 Lung Pulmonary Airway Disease Treatment Market Trends
2.3.2 Lung Pulmonary Airway Disease Treatment Market Drivers
2.3.3 Lung Pulmonary Airway Disease Treatment Market Challenges
2.3.4 Lung Pulmonary Airway Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lung Pulmonary Airway Disease Treatment Players by Revenue
3.1.1 Global Top Lung Pulmonary Airway Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Lung Pulmonary Airway Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Pulmonary Airway Disease Treatment Revenue
3.4 Global Lung Pulmonary Airway Disease Treatment Market Concentration Ratio
3.4.1 Global Lung Pulmonary Airway Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Pulmonary Airway Disease Treatment Revenue in 2020
3.5 Lung Pulmonary Airway Disease Treatment Key Players Head office and Area Served
3.6 Key Players Lung Pulmonary Airway Disease Treatment Product Solution and Service
3.7 Date of Enter into Lung Pulmonary Airway Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Pulmonary Airway Disease Treatment Breakdown Data by Type
4.1 Global Lung Pulmonary Airway Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Lung Pulmonary Airway Disease Treatment Breakdown Data by Application
5.1 Global Lung Pulmonary Airway Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lung Pulmonary Airway Disease Treatment Market Size (2016-2027)
6.2 North America Lung Pulmonary Airway Disease Treatment Market Size by Type
6.2.1 North America Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2027)
6.3 North America Lung Pulmonary Airway Disease Treatment Market Size by Application
6.3.1 North America Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2027)
6.4 North America Lung Pulmonary Airway Disease Treatment Market Size by Country
6.4.1 North America Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lung Pulmonary Airway Disease Treatment Market Size (2016-2027)
7.2 Europe Lung Pulmonary Airway Disease Treatment Market Size by Type
7.2.1 Europe Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Lung Pulmonary Airway Disease Treatment Market Size by Application
7.3.1 Europe Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Lung Pulmonary Airway Disease Treatment Market Size by Country
7.4.1 Europe Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lung Pulmonary Airway Disease Treatment Market Size (2016-2027)
9.2 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Type
9.2.1 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Application
9.3.1 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Country
9.4.1 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boehringer Ingelheim International
11.1.1 Boehringer Ingelheim International Company Details
11.1.2 Boehringer Ingelheim International Business Overview
11.1.3 Boehringer Ingelheim International Lung Pulmonary Airway Disease Treatment Introduction
11.1.4 Boehringer Ingelheim International Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
11.1.5 Boehringer Ingelheim International Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Lung Pulmonary Airway Disease Treatment Introduction
11.2.4 AstraZeneca Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Teva Pharmaceuticals
11.3.1 Teva Pharmaceuticals Company Details
11.3.2 Teva Pharmaceuticals Business Overview
11.3.3 Teva Pharmaceuticals Lung Pulmonary Airway Disease Treatment Introduction
11.3.4 Teva Pharmaceuticals Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
11.3.5 Teva Pharmaceuticals Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Lung Pulmonary Airway Disease Treatment Introduction
11.4.4 GSK Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Lung Pulmonary Airway Disease Treatment Introduction
11.5.4 Novartis Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Lung Pulmonary Airway Disease Treatment Introduction
11.6.4 Merck Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Lung Pulmonary Airway Disease Treatment Introduction
11.7.4 Roche Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Lung Pulmonary Airway Disease Treatment Introduction
11.8.4 Sanofi Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lung Pulmonary Airway Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Cytotoxic Drugs
Table 4. Key Players of Antibiotics
Table 5. Key Players of Others
Table 6. Global Lung Pulmonary Airway Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lung Pulmonary Airway Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lung Pulmonary Airway Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Lung Pulmonary Airway Disease Treatment Market Share by Regions (2016-2021)
Table 10. Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Lung Pulmonary Airway Disease Treatment Market Share by Regions (2022-2027)
Table 12. Lung Pulmonary Airway Disease Treatment Market Trends
Table 13. Lung Pulmonary Airway Disease Treatment Market Drivers
Table 14. Lung Pulmonary Airway Disease Treatment Market Challenges
Table 15. Lung Pulmonary Airway Disease Treatment Market Restraints
Table 16. Global Lung Pulmonary Airway Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Lung Pulmonary Airway Disease Treatment Market Share by Players (2016-2021)
Table 18. Global Top Lung Pulmonary Airway Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Pulmonary Airway Disease Treatment as of 2020)
Table 19. Ranking of Global Top Lung Pulmonary Airway Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Lung Pulmonary Airway Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lung Pulmonary Airway Disease Treatment Product Solution and Service
Table 23. Date of Enter into Lung Pulmonary Airway Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Lung Pulmonary Airway Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Boehringer Ingelheim International Company Details
Table 64. Boehringer Ingelheim International Business Overview
Table 65. Boehringer Ingelheim International Lung Pulmonary Airway Disease Treatment Product
Table 66. Boehringer Ingelheim International Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021) & (US$ Million)
Table 67. Boehringer Ingelheim International Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Lung Pulmonary Airway Disease Treatment Product
Table 71. AstraZeneca Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Teva Pharmaceuticals Company Details
Table 74. Teva Pharmaceuticals Business Overview
Table 75. Teva Pharmaceuticals Lung Pulmonary Airway Disease Treatment Product
Table 76. Teva Pharmaceuticals Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021) & (US$ Million)
Table 77. Teva Pharmaceuticals Recent Development
Table 78. GSK Company Details
Table 79. GSK Business Overview
Table 80. GSK Lung Pulmonary Airway Disease Treatment Product
Table 81. GSK Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021) & (US$ Million)
Table 82. GSK Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Lung Pulmonary Airway Disease Treatment Product
Table 86. Novartis Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Lung Pulmonary Airway Disease Treatment Product
Table 91. Merck Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Roche Company Details
Table 94. Roche Business Overview
Table 95. Roche Lung Pulmonary Airway Disease Treatment Product
Table 96. Roche Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021) & (US$ Million)
Table 97. Roche Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Revenue in Lung Pulmonary Airway Disease Treatment Business (2016-2021) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Pulmonary Airway Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Bronchodilators Features
Figure 3. Cytotoxic Drugs Features
Figure 4. Antibiotics Features
Figure 5. Others Features
Figure 6. Global Lung Pulmonary Airway Disease Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Lung Pulmonary Airway Disease Treatment Report Years Considered
Figure 11. Global Lung Pulmonary Airway Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Lung Pulmonary Airway Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lung Pulmonary Airway Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Lung Pulmonary Airway Disease Treatment Market Share by Regions (2022-2027)
Figure 15. Global Lung Pulmonary Airway Disease Treatment Market Share by Players in 2020
Figure 16. Global Top Lung Pulmonary Airway Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Pulmonary Airway Disease Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Lung Pulmonary Airway Disease Treatment Revenue in 2020
Figure 18. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Lung Pulmonary Airway Disease Treatment Market Share by Type (2016-2027)
Figure 22. North America Lung Pulmonary Airway Disease Treatment Market Share by Application (2016-2027)
Figure 23. North America Lung Pulmonary Airway Disease Treatment Market Share by Country (2016-2027)
Figure 24. United States Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lung Pulmonary Airway Disease Treatment Market Share by Type (2016-2027)
Figure 28. Europe Lung Pulmonary Airway Disease Treatment Market Share by Application (2016-2027)
Figure 29. Europe Lung Pulmonary Airway Disease Treatment Market Share by Country (2016-2027)
Figure 30. Germany Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Share by Region (2016-2027)
Figure 40. China Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lung Pulmonary Airway Disease Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Lung Pulmonary Airway Disease Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Lung Pulmonary Airway Disease Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Lung Pulmonary Airway Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Boehringer Ingelheim International Revenue Growth Rate in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Lung Pulmonary Airway Disease Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界の非びらん性胃食道逆流症治療市場規模・現状・予測（2021年-2027年）

Global Nonerosive Reflux Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5889 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、非びらん性胃食道逆流症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロトンポンプ阻害剤、H2受容体拮抗薬、制酸剤、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市場...

世界のパジェット病治療市場規模・現状・予測（2021年-2027年）

Global Paget's Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4647 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、パジェット病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、カルシトニン類似体（サーモンカルシトニン）、鎮痛剤、カルシウム・ビタミンDサプリメント）、用途別市場規模（病院、ク...

世界の経カテーテル肺動脈弁置換市場規模・現状・予測（2021年-2027年）

Global Transcatheter Pulmonary Valve Replacement Market Size, Status and Forecast 2021-2027
QFJ1-5367 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、経カテーテル肺動脈弁置換の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バルーン拡張、自己拡張）、用途別市場規模（病院、外科医院、心臓カテーテル検査室）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の末期腎疾患治療市場規模・現状・予測（2021年-2027年）

Global End Stage Renal Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4184 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、末期腎疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（移植、透析）、用途別市場規模（公立病院、私立病院）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア...

世界の顧みられない熱帯病（NTD）治療市場規模・現状・予測（2021年-2027年）

Global Neglected Tropical Disease (NTD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4558 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、顧みられない熱帯病（NTD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院・クリニック、診断センター、学術・研究機関）、主要地域別市場規模（北米、アメリカ...

世界の気管チューブ＆気道製品市場規模・現状・予測（2021年-2027年）

Global Tracheal Tube and Airway Products Market Size, Status and Forecast 2021-2027
QFJ1-5365 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、気管チューブ＆気道製品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（呼吸回路、気管切開チューブ、気管内チューブ、喉頭マスク、その他（喉頭鏡、口腔/鼻気道チューブ））、用途別市場規模（病院、在宅医療施...

世界の肺塞栓症治療薬市場規模・現状・予測（2021年-2027年）

Global Pulmonary Embolism Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5974 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、肺塞栓症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、...

世界の肺心臓弁置換市場規模・現状・予測（2021年-2027年）

Global Pulmonary Heart Valve Replacement Market Size, Status and Forecast 2021-2027
QFJ1-4786 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、肺心臓弁置換の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（開心術、低侵襲手術）、用途別市場規模（病院、救急センター、外来手術センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…
世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Polycystic Kidney Disease Treatment Drugs Market The global Polycystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…
世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の肺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing lung cancer Market Analysis and Insights: Global Lung Cancer Molecular Diagnostics Market The global Lung Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
世界のパジェット病治療市場規模・現状・予測（2021年-2027年） Paget's disease is a chronic condition which interferes with your body's normal bone remodeling process. ... Over time, the disease can cause affected bones to become fragile and misshapen. Paget's disease of bone most commonly occurs in the pelvis, skull, spine and legs. Market Analysis and Insight…